Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
about
Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseMicroRNAs that affect prostate cancer: emphasis on prostate cancer in African AmericansUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancerTumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.The clinicopathological significance of miR-133a in colorectal cancer.Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.miRNAs associated with prostate cancer risk and progressionTopologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case.MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinomaRole of microRNA-1 in human cancer and its therapeutic potentials.miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancersDecreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data.MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.MicroRNA-1 in Cardiac Diseases and CancersmiR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.Constructing higher-order miRNA-mRNA interaction networks in prostate cancer via hypergraph-based learning.Elucidating the evolutionary history and expression patterns of nucleoside phosphorylase paralogs (vegetative storage proteins) in Populus and the plant kingdom.EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance.Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.MiRBooking simulates the stoichiometric mode of action of microRNAs.MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.CancerNet: a database for decoding multilevel molecular interactions across diverse cancer types.Modulation of cancer traits by tumor suppressor microRNAs.Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologiesmiR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis.Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinomaTumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
P2860
Q26795757-D568354A-5348-4543-9616-0B1EA8B9D4D8Q27008271-D0F12578-AFBE-4E58-84EC-8152CF632B55Q28389159-BA467553-E0FB-4D16-BB27-4657E05E5FABQ28545072-57520628-ED0B-4C58-A185-2D1569933F57Q30009323-8DF4875E-8C0E-4898-A996-37D96FB54256Q30009338-B79A684F-BBE9-418B-A629-2C7088A57ACCQ30009425-F3284C21-BC30-4C5E-B31F-CD362A4BA76CQ30235186-D4305975-9CD6-4A22-AE43-046252688ECEQ30988064-AAA3FA72-411B-4C89-804D-5D0A9C20CAD7Q33590325-E655D716-42A6-4C8D-85FB-7135B5EF96C0Q33737275-7F731C28-80B8-4D16-A5D0-8CAF9AB71514Q33802900-2DE5EC34-7015-4A8E-8C38-FC4A823CCCA3Q34050751-918D622E-FB9C-454C-93F1-E97001A35347Q34093881-A988CA08-88D6-4B2B-BD9E-3906CE4B3122Q34231052-AE0C508A-5FE5-47E4-B3C5-3A8DC50800E3Q34245074-1E51B267-608F-4077-BD88-5619A5873545Q34252329-16028FE1-AAEB-442A-A4EE-691046552AB2Q34286271-8EB54F26-2ECA-4E0B-8676-48332FD75EBBQ34365861-52C5C0C6-4168-4781-9A3A-8DBFDAED9B90Q34412493-4D1BFC8B-18BA-45ED-A4DE-92F342F0F261Q34446954-6F5E5D04-E9A4-4BD9-85BA-C2DB865B98A1Q34775805-E34E0332-536E-4C35-B3C8-988F348A4EF4Q34778053-F73221C4-70B9-494E-9299-1E7CBBCB551DQ34956216-DD475E4D-6D6A-40C0-A091-BFC16510787EQ34956954-AA4135E8-D4BD-4DFF-9B31-4896544028D5Q35092566-12F16453-02AF-428D-AEA4-4D3545B1E01BQ35169337-C6AD37B5-1CA8-48F7-B67C-DA424C82CCDCQ35537955-B54442EA-F363-42A8-BDE0-BB4CA6EFBF10Q35799311-F8EB4474-9908-48C6-97ED-796F7DAE474DQ35961902-3D47290A-DC23-4B41-BB28-202C3897EC46Q36278121-F9BC8B32-E84D-4968-B061-C25A8D8B2C1AQ36396552-7B28FF6C-07EF-4ECF-8925-8A5595475EB5Q36590130-C9F5B3CA-747E-466D-82BB-F76F33084A9BQ36629543-2F3175D8-65EF-4CAA-835F-246ADF501F4AQ36983766-58F9649E-4627-4AAB-B961-1CC0362FF013Q37252292-4E1CF060-52F2-42E0-8561-2CE9B8DB7794Q37283359-EA17952C-035D-4283-8276-74BED3D967B0Q37295826-AA28069E-8C84-4EB7-97DE-EC96C1E7CF26Q37326148-2F552AD4-962C-40AA-BE0A-20A0F5DE9D7EQ37611692-03CC812D-C178-445E-A9CB-B78D1F41110A
P2860
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Tumour suppressors miR-1 and m ...... ylase (PNP) in prostate cancer
@en
Tumour suppressors miR-1 and m ...... urine nucleoside phosphorylase
@nl
type
label
Tumour suppressors miR-1 and m ...... ylase (PNP) in prostate cancer
@en
Tumour suppressors miR-1 and m ...... urine nucleoside phosphorylase
@nl
prefLabel
Tumour suppressors miR-1 and m ...... ylase (PNP) in prostate cancer
@en
Tumour suppressors miR-1 and m ...... urine nucleoside phosphorylase
@nl
P2093
P2860
P356
P1476
Tumour suppressors miR-1 and m ...... ylase (PNP) in prostate cancer
@en
P2093
K Kawakami
M Nakagawa
T Chiyomaru
T Ichikawa
P2860
P2888
P304
P356
10.1038/BJC.2011.462
P407
P577
2011-11-08T00:00:00Z